Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
For cytosolic ROS detection, the resulting cells were stained with 2.5 M DCFDA
Glutathione is depleted during stress, illness and aging
Femoral neck BMD decreased after using dulaglutide, although not as much as when using a placebo
It helps iron cross the intestinal barrier and it helps glutathione stay in its "reduced" (active) state
Published literature: Documented effects on sleep architecture and cortisol modulation in published studies Therapeutic Peptides Comparison Table Peptide Category FDA Status Primary Research Application BPC-157 Tissue Repair Category 1 (2026) Tendon, ligament, GI repair TB-500 Tissue Repair Category 1 (2026) Soft tissue, cell migration Retatrutide Metabolic Phase 3 trials Obesity, metabolic syndrome Tirzepatide Metabolic FDA-approved Type 2 diabetes, obesity Tesamorelin Metabolic / GH FDA-approved Lipodystrophy, visceral fat GHK-Cu Skin / Repair Not approved Wound healing, collagen CJC-1295 GH Secretagogue Category 1 (2026) Growth hormone release Ipamorelin GH Secretagogue Category 1 (2026) Selective GH release Selank Cognitive Category 1 (2026) Anxiety, GABA modulation Semax Cognitive Category 1 (2026) Memory, BDNF pathways KPV Anti-inflammatory Not approved Gut inflammation, skin PT-141 Neurological FDA-approved Sexual health (HSDD) SS-31 Mitochondrial FDA-approved Barth syndrome, mito dysfunction MOTS-c Mitochondrial Not approved Insulin sensitivity, exercise Humanin Cytoprotective Not approved Neuroprotection, aging DSIP Neurological Not approved Sleep regulation 2026 FDA Peptide Reclassification On February 27, 2026, HHS Secretary Robert F
While BPC-157 focuses on localized tissue repair and new blood vessel formation, TB-500 works systemically to regulate cellular movement and reduce inflammation across the body
US$ 26.17
US$ 22.30
US$ 23.72
US$ 21.73
US$ 20.36
US$ 23.68
US$ 25.11
US$ 27.20
US$ 29.62
US$ 22.02
US$ 29.33
US$ 28.77
US$ 29.72
